Brands: Novolog · Insulin Aspart
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Novo Nordisk | unknown | 12 | SUPPLYING |
| A-S Medication Solutions | repackager | 5 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Insulin Aspart Injection — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
Insulin Aspart Injection — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors. — Recalling firm: Novo Nordisk Inc — Nationwide in the USA
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors. — Recalling firm: Novo Nordisk Inc — Nationwide in the USA
